Yüklüyor......
Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
SIMPLE SUMMARY: Immune checkpoint blockade targeting PD-1/PD-L1 has a promising therapeutic efficacy in different tumors, but a significant percentage of patients cannot benefit from this therapy due to primary and acquired resistance during treatment. This review summarizes the recent findings of P...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915065/ https://ncbi.nlm.nih.gov/pubmed/33562324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040663 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|